All Pathways
Critical CareManagement

ICU Sedation Management (PADIS Guidelines)

ICU Sedation Management (PADIS Guidelines): Mechanically Ventilated Patient Requiring Sedation → Address Pain FIRST (Analgosedation) → Set Sedation Targ...

Pathway Overview

15 steps

Algorithm Steps

15 total

  1. 01Start

    Mechanically Ventilated Patient Requiring Sedation

    Assess need for sedation after addressing pain, delirium, physiologic needs

  2. 02Action

    Address Pain FIRST (Analgosedation)

    Pain is primary driver of agitation - treat before sedatives

    • Use validated pain scale (CPOT, BPS)
    • Opioid analgesia as first-line
    • Fentanyl preferred for hemodynamic stability
    • Consider multimodal analgesia
  3. 03Action

    Set Sedation Target: LIGHT (RASS 0 to -2)

    Strong recommendation for light sedation in most patients

    • RASS 0: Alert and calm
    • RASS -1: Drowsy, sustained awakening >10s
    • RASS -2: Light sedation, brief awakening <10s
    • Document target in orders
  4. 04Decision

    Special Deep Sedation Indication?

    Most patients should target light sedation

    • ARDS with ventilator dyssynchrony
    • Therapeutic hypothermia
    • Refractory ICP elevation
    • NMBA use (must be deeply sedated)
  5. 05Action

    Deep Sedation (RASS -4 to -5)

    Reserved for specific indications

    • Target RASS -4 to -5
    • Daily reassessment for lightening
    • Monitor for over-sedation complications
    • Plan for transition to light sedation
  6. 06Action

    Daily Sedation Assessment

    Reassess sedation needs every shift

    • Spontaneous Awakening Trial (SAT)
    • Coordinate with SBT for ventilator weaning
    • Reduce infusion to lowest effective dose
    • Target lightest tolerated sedation
  7. 07Decision

    Breakthrough Agitation?

    RASS +1 to +4

  8. 08Action

    Address Underlying Cause

    Before escalating sedation

    • Pain - treat with analgesia
    • Delirium - CAM-ICU, non-pharm first
    • Hypoxia, hypercapnia
    • Full bladder, constipation
    • Anxiety - consider dexmedetomidine
  9. 09Action

    Escalate Sedation

    If agitation persists after addressing causes

    • Increase current agent
    • Add second agent
    • Consider short-term deeper target
    • Reassess daily for de-escalation
  10. 10Outcome

    Deep Sedation Required

    Daily reassessment for lightening

  11. 11Outcome

    Light Sedation Achieved

    RASS 0 to -2, awake for participation in care

  12. Path rejoins step 11Shared downstream outcome
  13. 12Decision

    Select Sedation Agent

    Dexmedetomidine vs Propofol

  14. 13Action

    Dexmedetomidine (Precedex)

    PADIS 2025: Suggest over propofol when light sedation or delirium reduction priority

    • Load: 0.5-1 mcg/kg over 10-20 min (optional)
    • Infusion: 0.2-0.7 mcg/kg/hr
    • Max: 1.5 mcg/kg/hr
    • ⚠️ Risk: Bradycardia, hypotension
    • Benefit: Less delirium, better awakening
  15. Path rejoins step 06Shared downstream outcome
  16. 14Action

    Propofol

    Alternative for lighter sedation, rapid awakening

    • Start: 5-10 mcg/kg/min
    • Titrate: 5-50 mcg/kg/min
    • Max: 80 mcg/kg/min (PRIS risk)
    • ⚠️ Monitor triglycerides if >48h
    • ⚠️ PRIS risk at high doses/prolonged use
  17. Path rejoins step 06Shared downstream outcome
  18. 15Warning

    ⚠️ Avoid Benzodiazepines

    Associated with worse outcomes

    • Increased delirium risk
    • Longer mechanical ventilation
    • Exception: alcohol withdrawal, seizures
    • PADIS: Suggest against routine use

Guideline Source

A Focused Update to the Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address procedural sedation
  • Assumes mechanically ventilated patient
  • Neurosurgical patients may need deeper sedation targets
  • Drug dosing varies by institution and patient factors
  • Does not address alcohol withdrawal requiring high-dose benzos

Contraindicated Populations

pediatric

Applicable Regions

USEUGlobal

Global: PADIS guidelines widely adopted

Version 1Next review: 2028-01-01

Frequently Asked Questions

What is the ICU Sedation Management (PADIS Guidelines)?

The ICU Sedation Management (PADIS Guidelines) is a management clinical algorithm for Critical Care. It provides a structured decision tree to guide clinical decision-making, based on A Focused Update to the Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU.

What guideline is the ICU Sedation Management (PADIS Guidelines) based on?

This algorithm is based on A Focused Update to the Clinical Practice Guidelines for the Prevention and Management of Pain, Anxiety, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (DOI: 10.1097/CCM.0000000000006574).

What are the limitations of the ICU Sedation Management (PADIS Guidelines)?

Known limitations include: Does not address procedural sedation; Assumes mechanically ventilated patient; Neurosurgical patients may need deeper sedation targets; Drug dosing varies by institution and patient factors; Does not address alcohol withdrawal requiring high-dose benzos. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the ICU Sedation Management (PADIS Guidelines) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free